These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4139295)

  • 21. The genetic basis of cross-resistance between streptomycin, viomycin and kanamycin of tubercle bacilli and atypical mycobacteria.
    Bönicke J; Bönicke R
    Bull Int Union Tuberc; 1970 Jun; 43():229-34. PubMed ID: 4316621
    [No Abstract]   [Full Text] [Related]  

  • 22. The antimycobacterial activity of capreomycin.
    Lucchesi M
    Antibiot Chemother; 1970; 16():27-31. PubMed ID: 4108891
    [No Abstract]   [Full Text] [Related]  

  • 23. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
    Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N
    Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
    [No Abstract]   [Full Text] [Related]  

  • 24. [Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients].
    Endo K
    Jpn J Antibiot; 1970 Aug; 23(4):387-9. PubMed ID: 4321638
    [No Abstract]   [Full Text] [Related]  

  • 25. [In vitro antituberculous activity of lividomycin].
    Kobayashi F; Nagoya T; Eda J; Yoshimura Y
    Jpn J Antibiot; 1972 Dec; 25(6):360-6. PubMed ID: 4125073
    [No Abstract]   [Full Text] [Related]  

  • 26. Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubecle bacilli from paients.
    Tsukamura M
    Am Rev Respir Dis; 1969 May; 99(5):780-2. PubMed ID: 4306213
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of viomycin on dihydrostreptomycin binding to bacterial ribosomes.
    Masuda K; Yamada T
    Biochim Biophys Acta; 1976 Jul; 435(4):333-9. PubMed ID: 60132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of some aminoglycosides upon a drug dependent Escherichia coli strain.
    Gadó I; Dumbovich I
    Acta Microbiol Acad Sci Hung; 1975; 22(2):95-104. PubMed ID: 1092134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STUDIES ON CROSS-RESISTANCE BETWEEN CAPREOMYCIN AND CERTAIN OTHER ANTI-MYCOBACTERIAL AGENTS.
    KOSEKI Y; OKAMOTO S
    Jpn J Med Sci Biol; 1963 Feb; 16():31-8. PubMed ID: 14044251
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigation into the relationship of M ulcerans to M. buruli and other mycobacteria.
    Schröder KH
    Am Rev Respir Dis; 1975 Apr; 111(4):559-62. PubMed ID: 47730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The susceptibility of mycobacteria to rifamide and rifampicin.
    Clark J; Wallace A
    Tubercle; 1967 Jun; 48(2):144-8. PubMed ID: 4293697
    [No Abstract]   [Full Text] [Related]  

  • 32. Genetic recombination in mycobacteria.
    Tokunaga T; Mizuguchi Y; Suga K
    J Bacteriol; 1973 Mar; 113(3):1104-11. PubMed ID: 4691386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-resistance test for kanamycin and cross resistance problem in Mycobacterium tuberculosis with special reference to kanamycin, streptomycin, and viomycin.
    TSUKAMURA M
    J Antibiot (Tokyo); 1959 Jul; 12():189-91. PubMed ID: 13855139
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
    Tsukamura M
    Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effectiveness of the drugs of streptomycin group in experimental studies on albino mice infected with Mycobacterium tuberculosis resistant to these drugs].
    Kozulitsyna TI; Kozlova NV
    Probl Tuberk; 1976 Sep; (9):70-4. PubMed ID: 64981
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM; Mkrtchian SV; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract]   [Full Text] [Related]  

  • 37. Pleiotropic antibiotic resistance mutations associated with ribosomes and ribosomal subunits in Mycobacterium smegmatis.
    Yamada T; Masuda K; Shoji K; Hori M
    Antimicrob Agents Chemother; 1974 Jul; 6(1):46-53. PubMed ID: 15828170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
    Saito T; Fukuhara Y
    Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
    [No Abstract]   [Full Text] [Related]  

  • 39. Semisynthesis of di-beta-lysylcapreomycin IIA, a capreomycin analog effective against viomycin-resistant Mycobacterium.
    Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1983 Feb; 36(2):197-9. PubMed ID: 6187721
    [No Abstract]   [Full Text] [Related]  

  • 40. [Crossed resistance in vitro to kanamycin, farmiglucine, streptomycin and neomycin].
    Tallarida G; Pierangeli L; Vellucci A; Donati G
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):1665-7. PubMed ID: 5877897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.